Exact Mass: 409.2188

Exact Mass Matches: 409.2188

Found 38 metabolites which its exact mass value is equals to given mass value 409.2188, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Acidissiminol epoxide

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidate

C25H31NO4 (409.2253)


Acidissiminol epoxide is found in beverages. Acidissiminol epoxide is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Acidissiminol epoxide is found in beverages and fruits.

   

3-N-Methylspiperone

8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

C24H28FN3O2 (409.2165)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Anthra(1,9-cd)pyrazol-6(2H)-one, 2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-

14-{2-[(2-hydroxyethyl)amino]ethyl}-10-({2-[(2-hydroxyethyl)amino]ethyl}amino)-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9,11,13(16)-heptaen-8-one

C22H27N5O3 (409.2114)


   

Butaperazine

1-{10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazin-2-yl}butan-1-one

C24H31N3OS (409.2188)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

isariotin C

isariotin C

C21H31NO7 (409.21)


   

callosine

callosine

C21H31NO7 (409.21)


   
   
   
   
   
   

Meptazinol glucuronide

Meptazinol glucuronide

C21H31NO7 (409.21)


   

Severin

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzamide

C25H31NO4 (409.2253)


   
   

(R,E)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate

(R,E)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate

C25H31NO4 (409.2253)


   

(S)-N-Fmoc-Octylglycine

(S)-N-Fmoc-Octylglycine

C25H31NO4 (409.2253)


   

(R)-N-Fmoc-Octylglycine

(R)-N-Fmoc-Octylglycine

C25H31NO4 (409.2253)


   

Butaperazine

Butaperazine

C24H31N3OS (409.2188)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

(3S,4aR,6aR,12aR,12bS)-3-Hydroxy-4,4,6a,12b-tetramethyl-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydrobenzo[f]pyrano[4,3-b]chromen-11(2H)-one

(3S,4aR,6aR,12aR,12bS)-3-Hydroxy-4,4,6a,12b-tetramethyl-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydrobenzo[f]pyrano[4,3-b]chromen-11(2H)-one

C25H31NO4 (409.2253)


   

[(1S)-1-[(4-fluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1S)-1-[(4-fluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C24H28FN3O2 (409.2165)


   

3-((2E,6E)-9-((S)-3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl)-4-hydroxy-6-(pyridin-3-yl)-2H-pyran-2-one

3-((2E,6E)-9-((S)-3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl)-4-hydroxy-6-(pyridin-3-yl)-2H-pyran-2-one

C25H31NO4 (409.2253)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate

C18H36NO7P (409.2229)


   

3-N-Methylspiperone

3-N-Methylspiperone

C24H28FN3O2 (409.2165)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

deacetylpyripyropene E

deacetylpyripyropene E

C25H31NO4 (409.2253)


An organic heterotetracyclic compound that is (3S,4aR,6aR,12aR,12bS)-3-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-11-one substituted by a pyridin-3-yl group at position 9 (the 3S,4aR,6aR,12aR,12bS stereoisomer).

   

NA-Taurine 20:5(5Z,8Z,11Z,14Z,17Z)

NA-Taurine 20:5(5Z,8Z,11Z,14Z,17Z)

C22H35NO4S (409.2287)


   
   

ST 19:2;O5;Gly

ST 19:2;O5;Gly

C21H31NO7 (409.21)


   

ST 23:6;O2;Gly

ST 23:6;O2;Gly

C25H31NO4 (409.2253)


   

4-PPBP (maleate)

4-PPBP (maleate)

C25H31NO4 (409.2253)


4-PPBP maleate is a potent σ 1 receptor ligand and agonist. 4-PPBP maleate is a non-competitive, selective NR1a/2B NMDA receptors (expressed in Xenopus oocytes) antagonist. 4-PPBP maleate provides neuroprotection[1][2][3].

   

n-[2-(4-{[(2e,4r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e,4r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

6-hydroxy-4,5,6-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl 2-methylbutanoate

6-hydroxy-4,5,6-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl 2-methylbutanoate

C21H31NO7 (409.21)


   

n-[2-(4-{[5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

n-[2-(4-{[(2e)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

(2e)-7-oxo-n-[(1s,2s,4s,5s,6s,7r,8s)-1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]dodec-2-enimidic acid

(2e)-7-oxo-n-[(1s,2s,4s,5s,6s,7r,8s)-1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]dodec-2-enimidic acid

C21H31NO7 (409.21)


   

7-oxo-n-{1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl}dodec-2-enimidic acid

7-oxo-n-{1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl}dodec-2-enimidic acid

C21H31NO7 (409.21)


   

methyl 2-{8-hydroxy-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-14-yl}acetate

methyl 2-{8-hydroxy-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-14-yl}acetate

C21H31NO7 (409.21)


   

methyl (2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-[2-(6-methylheptyl)-1,3-thiazol-4-yl]hepta-2,6-dienoate

methyl (2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-[2-(6-methylheptyl)-1,3-thiazol-4-yl]hepta-2,6-dienoate

C22H35NO4S (409.2287)


   

methyl 2-[(1r,4z,7r,8r,12s,14r,18r)-8-hydroxy-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-14-yl]acetate

methyl 2-[(1r,4z,7r,8r,12s,14r,18r)-8-hydroxy-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-14-yl]acetate

C21H31NO7 (409.21)